Biotechnology
Idera Pharmaceuticals Climbs 16.9%, Phase 3 Study Proceeds
A clinical-stage biotech company advancing novel therapies for skin-related diseases, Idera Pharmaceuticals Inc. (NASDAQ:$IDRA) saw its shares surge today. This came after the company presented trial results at the annual European Society for Medical Oncology ... [Read]
Biotechnology
Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report
Plummeting 6.8%, way outperforming the market, Immune Design Corp. (NASDAQ:$IMDZ)’s shares are suffering a serious outlook. Let’s take a look back on Immune Design’s last earnings report. Narrower-than-expected Loss in Q2 The company incurred 2Q17 ... [Read]
Biotechnology
The Market Empties On Otonomy Inc. Stock
Following truly abysmal results from a pivotal Phase 3 trial for its steroid candidate Otividex, Otonomy Inc. (NASDAQ:$OTIC) saw its investors parachuting out of their shares. The number? A cool 81.5% decrease. While about 600,000 ... [Read]
Biotechnology
Cara Therapeutics Stock Increases After Revealing Promising Data From a Phase 1 Drug Trial
On Wednesday, Cara Therapeutics (NASDAQ:$CARA) stock increased after the biotech company revealed promising data from a Phase 1 drug trial for chronic kidney disease patients. If you’re a biotech investor, you are probably aware of ... [Read]
Biotechnology
Celsion Corp’s Stock Increased Almost 25% Today
On Wednesday, July 5, in a morning trading session, shares of Celsion Corp. (NASDAQ:$CLSN) increased almost 25% to $2.53. This jump occurred after the New Jersey-based firm disclosed the completion of the Ovation study, a ... [Read]
Biotechnology
A British Biotech Company is Close to a Breakthrough Blood Test for Diagnosing Ovarian Cancer
On Monday, U.K-based biotech company Angle plc (OTCQX:$ANPCY) disclosed the trial results of a possible breakthrough blood test for diagnosing ovarian cancer. Essentially, Angle’s blood test could allow for a quicker diagnosis and referral for women ... [Read]
Biotechnology
Should You Invest in Conatus Pharmaceuticals Inc.?
Conatus Pharmaceuticals Inc. (NASDAQ:$CNAT), a biotech-pharmaceutical company focused on developing drugs to treat liver disease, has been seeing quite a rise in its stocks recently. This can be largely due to the company’s announcement a ... [Read]
Biotechnology
NewLink Genetics Stocks Crash after Roche Holdings Back Out of Co-Development Deal
The Upshot An unexpected decision made by Roche Holding (NASDAQOTH:$RHHBY), a healthcare company based in Basel, Switzerland, has sent the shares of NewLink Genetics Corporation (NASDAQ:$NLNK), a biotech research company focusing on cancer treatments based ... [Read]
Biotechnology
The 3 Junior Biotech to Watch Out for in 2017
Despite the broader sector of the market underperforming in comparison to other market groups, investors are continuing to test the waters of junior biotech. In 2016, there was a massive attack on industry price fixing ... [Read]
Biotechnology
President and CEO of VBI Vaccines Set to Present at Jefferies 2017 Global Healthcare Conference
VBI Vaccines Inc. (NASDAQ:$VBIV), a biopharmaceutical company headquartered in Cambridge, MA, announced today that VBI’s President and CEO, Jeff Baxter, will be presenting at the Jefferies 2017 Global Healthcare Conference on Friday, June 9, 2017 ... [Read]